Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Bakersfield › NPI 1376623538

Kern County Hospital Authority

Kern County Hospital Authority was paid $169.30M by Medicaid between Jan 2018 and Dec 2024, across 533 billing codes. Its largest line is G0390, Trauma response team associated with hospital critical care service — 27% of everything it billed.

33Billing provider infoKERN COUNTY HOSPITAL AUTHORITY
BAKERSFIELD, CA 93306
33aNPI1376623538assigned 10/16/2006
33bProvider typeCase Manager/Care Coordinator
28Total paid$169.30M
24GClaims2,746,824
24DCodes billed533
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Case Manager/Care Coordinator providers in California

Rank by total paid#4 of 435
Median peer was paid$2.89M
This provider vs. median59×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$2.0M$4.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018272,929$18.29M
2019255,784$17.66M
2020330,652$20.46M
2021431,845$26.11M
2022451,618$25.72M
2023477,833$29.22M
2024incomplete526,163$31.83M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
G0390 Trauma response team associated with hospital critical care service 27% 3,980 3,874 $46.51M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 21% 122,675 113,703 $35.15M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 16% 66,578 55,889 $26.30M
0450 Emergency room services 4.6% 16,579 14,567 $7.76M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 4.0% 89,343 87,743 $6.71M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 2.4% 91,953 74,779 $4.11M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1.6% 3,153 2,165 $2.76M
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.2% 33,916 33,520 $2.00M
0762 1.2% 2,552 1,201 $1.98M
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 22,687 21,796 $1.62M
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 1,620 1,120 $1.52M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 11,543 11,400 $1.22M
521 more codes
99232 Hospital visit by a doctor, follow-up day <1% 29,278 $1.16M
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 542 $1.16M
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 1,470 $1.06M
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 9,063 $1.06M
99214 Doctor's office visit, returning patient (more involved) <1% 18,923 $789K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 37,436 $767K
76818 <1% 18,686 $752K
88307 <1% 9,878 $670K
80053 Comprehensive metabolic panel <1% 92,329 $660K
99213 Doctor's office visit, returning patient (routine) <1% 19,508 $638K
84443 Thyroid stimulating hormone (TSH) <1% 49,472 $595K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 1,235 $595K
99238 Hospital discharge day management, 30 minutes or less <1% 14,239 $589K
99204 Doctor's office visit, new patient (more involved) <1% 6,751 $565K
99233 Hospital visit by a doctor, follow-up day (complex) <1% 13,276 $558K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 127,809 $506K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 16,457 $505K
70450 Computed tomography, head or brain; without contrast material <1% 21,263 $498K
80061 Lipid panel <1% 46,158 $452K
77067 Screening mammography, bilateral, including computer-aided detection <1% 6,204 $425K
59409 Vaginal delivery only (with or without episiotomy and/or forceps) <1% 669 $422K
83036 Hemoglobin; glycosylated (A1C) <1% 58,178 $415K
99460 <1% 7,110 $408K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 11,960 $386K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 24,948 $383K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 18,529 $374K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 18,525 $372K
86480 <1% 11,272 $370K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 26,780 $343K
71045 Radiologic examination, chest; single view <1% 58,491 $337K
99070 <1% 105,355 $330K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 5,706 $328K
99223 Prolong inpt eval add15 m <1% 3,965 $320K
99222 Initial hospital care, per day, moderate complexity <1% 4,098 $316K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 9,455 $298K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 13,741 $275K
71046 Radiologic examination, chest; 2 views <1% 33,660 $274K
Z1034 <1% 5,027 $255K
80048 Basic metabolic panel (calcium, ionized) <1% 50,430 $247K
86171 <1% 17,051 $239K
80074 <1% 7,132 $238K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 8,494 $238K
J7307 Etonogestrel (contraceptive) implant system, including implant and supplies <1% 155 $205K
84439 <1% 31,322 $199K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 1,988 $196K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 1,012 $196K
86331 <1% 17,089 $192K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 3,276 $173K
76770 <1% 4,387 $167K
Q3014 Telehealth originating site facility fee <1% 6,936 $166K
72125 Computed tomography, cervical spine; without contrast material <1% 7,882 $164K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 5,631 $163K
86003 <1% 1,531 $160K
86780 <1% 19,307 $153K
77066 Tomosynthesis, mammo <1% 1,611 $149K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 7,552 $144K
86803 <1% 14,732 $136K
96361 Intravenous infusion, hydration; each additional hour <1% 13,360 $136K
76642 <1% 2,706 $129K
87086 Culture, bacterial; quantitative colony count, urine <1% 31,196 $128K
95720 <1% 663 $127K
99203 Doctor's office visit, new patient (routine) <1% 2,066 $121K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 9,272 $114K
76801 <1% 3,305 $111K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 837 $111K
71250 <1% 1,418 $105K
74178 <1% 456 $98K
87536 <1% 1,618 $97K
76641 <1% 1,876 $96K
86235 <1% 4,157 $94K
81001 <1% 68,013 $93K
99243 <1% 1,610 $92K
94729 <1% 2,918 $92K
76830 Ultrasound, transvaginal <1% 2,526 $92K
87340 <1% 11,626 $90K
80076 <1% 23,697 $90K
94726 <1% 2,894 $89K
0710 <1% 7,213 $87K
59025 Fetal non-stress test <1% 7,942 $87K
87522 Neg quan hep c or qual rna <1% 2,448 $85K
82570 <1% 21,281 $85K
94060 <1% 3,074 $84K
83970 <1% 2,933 $84K
99239 Hospital discharge day management, more than 30 minutes <1% 1,580 $81K
82043 <1% 18,416 $79K
99462 <1% 2,749 $78K
97597 <1% 1,497 $73K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 7,292 $73K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 23,875 $70K
88304 <1% 3,317 $66K
73110 <1% 6,702 $63K
82728 <1% 6,189 $62K
99464 <1% 808 $61K
82105 <1% 2,933 $61K
73630 <1% 7,531 $61K
99215 Doctor's office visit, returning patient (complex) <1% 854 $59K
77065 Tomosynthesis, mammo <1% 783 $59K
73130 <1% 8,336 $59K
86140 <1% 16,686 $58K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 2,857 $58K
73610 <1% 7,348 $58K
90791 Psychiatric diagnostic evaluation <1% 358 $58K
83880 <1% 4,227 $57K
73562 <1% 8,036 $55K
76536 <1% 1,479 $54K
99231 Subsequent hospital care, per day, straightforward or low complexity <1% 2,028 $51K
72100 <1% 3,471 $51K
86762 <1% 4,665 $51K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 1,442 $50K
0510 <1% 2,066 $50K
83735 <1% 22,192 $49K
99152 <1% 1,392 $48K
86317 <1% 7,855 $48K
A9577 Injection, gadobenate dimeglumine (multihance), per ml <1% 1,452 $48K
85610 <1% 24,338 $47K
73030 <1% 5,434 $47K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 442 $45K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 1,283 $45K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 5,543 $44K
88312 <1% 2,579 $44K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 122 $43K
99244 Office or other outpatient consultation, moderate to high complexity <1% 430 $43K
86255 <1% 4,451 $42K
80299 <1% 3,248 $42K
85730 <1% 18,266 $42K
70551 Magnetic resonance imaging, brain; without contrast material <1% 343 $42K
70486 <1% 1,317 $41K
83550 <1% 7,078 $41K
20680 <1% 23 $40K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 339 $40K
90674 <1% 920 $38K
95700 <1% 168 $38K
83540 <1% 8,074 $38K
86160 <1% 3,062 $37K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 714 $37K
71275 Computed tomographic angiography, chest, with contrast material <1% 778 $34K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 21,520 $34K
J7030 Infusion, normal saline solution , 1000 cc <1% 10,635 $33K
82607 <1% 3,245 $33K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 1,500 $32K
87186 <1% 7,000 $30K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 2,235 $30K
85652 <1% 16,024 $29K
84100 <1% 19,635 $29K
74018 <1% 4,114 $29K
84153 <1% 4,730 $29K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 442 $29K
87529 <1% 913 $28K
86704 <1% 4,372 $27K
93351 <1% 187 $27K
H1001 Prenatal care, at-risk enhanced service; antepartum management <1% 568 $26K
93970 <1% 433 $26K
86360 <1% 1,149 $26K
96375 Therapeutic injection; each additional sequential IV push <1% 15,207 $26K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 15,082 $25K
85018 <1% 14,136 $25K
90739 <1% 217 $25K
25600 <1% 285 $25K
93971 <1% 1,297 $25K
95718 <1% 210 $25K
85027 <1% 6,623 $24K
99381 <1% 212 $24K
82378 <1% 1,693 $24K
86708 <1% 3,307 $23K
86039 <1% 3,459 $23K
83690 <1% 19,022 $23K
86038 <1% 7,822 $23K
0001A <1% 619 $23K
86200 <1% 2,959 $23K
87077 <1% 5,482 $22K
73590 <1% 3,646 $22K
84702 <1% 4,572 $22K
73080 <1% 2,451 $21K
99254 <1% 280 $21K
95886 <1% 368 $21K
86901 <1% 13,612 $21K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 920 $21K
86850 <1% 11,950 $21K
81025 <1% 22,434 $20K
0370 <1% 7,475 $20K
83655 <1% 4,574 $20K
M0222 Intravenous injection, bebtelovimab, includes injection and post administration monitoring <1% 64 $20K
82247 <1% 5,402 $20K
82950 <1% 5,198 $19K
76857 <1% 905 $19K
Q9956 Injection, octafluoropropane microspheres, per ml <1% 190 $19K
86592 <1% 7,509 $18K
86021 <1% 1,303 $18K
0002A <1% 437 $17K
J7120 Ringers lactate infusion, up to 1000 cc <1% 4,021 $17K
82397 <1% 1,255 $17K
90662 <1% 185 $17K
0760 <1% 932 $17K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 1,049 $17K
86431 <1% 3,911 $17K
83883 <1% 1,056 $17K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,543 $16K
72040 <1% 1,044 $15K
84154 <1% 3,665 $15K
90715 <1% 3,717 $15K
70498 <1% 380 $15K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 10,839 $15K
82746 <1% 1,297 $14K
86705 <1% 1,498 $14K
83001 <1% 951 $13K
82951 <1% 1,209 $13K
84403 <1% 1,984 $13K
77080 <1% 298 $13K
86900 <1% 7,284 $12K
90686 <1% 728 $12K
73120 <1% 1,136 $12K
73502 <1% 856 $12K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 208 $12K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 896 $12K
82731 <1% 500 $11K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 610 $11K
99253 <1% 212 $11K
83516 <1% 812 $11K
93271 <1% 146 $11K
84146 <1% 748 $11K
86812 <1% 814 $11K
73090 <1% 2,284 $10K
82248 <1% 2,848 $10K
83615 <1% 2,560 $10K
84550 <1% 3,156 $10K
73560 <1% 886 $10K
90694 <1% 115 $10K
83002 <1% 684 $9K
45390 <1% 54 $9K
76000 <1% 1,518 $9K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 1,762 $9K
73221 <1% 73 $9K
95713 <1% 13 $9K
82565 <1% 2,463 $9K
86225 <1% 1,605 $9K
84480 <1% 1,834 $9K
12002 <1% 1,056 $9K
93270 <1% 283 $9K
88302 <1% 501 $9K
82785 <1% 1,276 $9K
E0114 Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips <1% 128 $9K
84156 <1% 3,087 $9K
J2270 Injection, morphine sulfate, up to 10 mg <1% 14,318 $9K
99463 <1% 80 $9K
73700 <1% 201 $9K
87109 <1% 670 $8K
95911 <1% 82 $8K
82330 <1% 909 $8K
82948 <1% 14,653 $8K
86376 <1% 1,005 $8K
20550 <1% 191 $8K
70496 <1% 123 $8K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 235 $8K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 14,430 $8K
83010 <1% 746 $8K
86706 <1% 1,977 $8K
76870 <1% 348 $8K
82977 <1% 2,266 $7K
81003 <1% 4,923 $7K
73564 <1% 690 $7K
P9011 Blood, split unit <1% 5,385 $7K
72170 <1% 2,062 $7K
82533 <1% 603 $7K
88300 <1% 1,363 $7K
84445 <1% 243 $7K
P9016 Red blood cells, leukocytes reduced, each unit <1% 120 $7K
82150 <1% 1,507 $7K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 4,620 $7K
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg <1% 1,449 $7K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 2,264 $7K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 3,839 $7K
J3490 Unclassified drugs <1% 13,082 $7K
82172 <1% 470 $7K
84402 <1% 1,165 $7K
95951 <1% 30 $6K
96127 <1% 1,662 $6K
99245 <1% 52 $6K
V5008 Hearing screening <1% 204 $6K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 12,773 $6K
87210 <1% 5,631 $6K
25605 <1% 58 $6K
20605 <1% 164 $6K
M0247 Intravenous infusion, sotrovimab, includes infusion and post administration monitoring <1% 18 $6K
99606 <1% 377 $6K
83519 <1% 409 $5K
86695 <1% 1,419 $5K
84484 <1% 9,184 $5K
86696 <1% 1,417 $5K
80055 <1% 174 $5K
82784 <1% 761 $5K
93000 <1% 253 $5K
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography <1% 12 $5K
82550 <1% 2,733 $5K
J7060 5% dextrose/water (500 ml = 1 unit) <1% 669 $5K
87088 <1% 1,412 $5K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 4,889 $5K
87070 <1% 2,032 $5K
73100 <1% 445 $5K
84481 <1% 967 $5K
45384 <1% 13 $4K
96156 <1% 92 $4K
86800 <1% 745 $4K
88108 <1% 206 $4K
99205 Prolong outpt/office vis <1% 44 $4K
95714 <1% 15 $4K
95861 <1% 158 $4K
70491 <1% 65 $4K
90677 <1% 12 $4K
82947 <1% 1,317 $4K
86300 <1% 448 $4K
73552 <1% 562 $4K
76819 Fetal biophysical profile; without non-stress testing <1% 116 $4K
J0690 Injection, cefazolin sodium, 500 mg <1% 2,955 $4K
82672 <1% 205 $4K
17250 <1% 182 $4K
86301 <1% 484 $4K
85014 <1% 1,958 $3K
84703 <1% 2,321 $3K
93308 <1% 467 $3K
86341 <1% 109 $3K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 5,699 $3K
90744 <1% 340 $3K
83525 <1% 451 $3K
83520 <1% 2,560 $3K
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) <1% 2,338 $3K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 2,166 $3K
87081 <1% 586 $3K
73140 <1% 391 $3K
84157 <1% 1,244 $3K
80069 <1% 409 $3K
99255 <1% 31 $3K
J1250 Injection, dobutamine hydrochloride, per 250 mg <1% 67 $3K
89051 <1% 1,580 $3K
82272 <1% 1,670 $3K
99153 Mod sedat endo service >5yrs <1% 2,230 $2K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 65 $2K
82627 <1% 343 $2K
J1170 Injection, hydromorphone, up to 4 mg <1% 2,013 $2K
84165 <1% 704 $2K
99221 <1% 56 $2K
86304 <1% 319 $2K
90670 <1% 250 $2K
87102 <1% 377 $2K
84425 <1% 247 $2K
84460 <1% 464 $2K
0004A <1% 57 $2K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 5,466 $2K
90647 <1% 222 $2K
84155 <1% 705 $2K
72070 <1% 116 $2K
12001 <1% 1,179 $2K
99465 <1% 12 $2K
96367 <1% 453 $2K
26600 <1% 12 $2K
73060 <1% 274 $2K
86593 <1% 1,266 $2K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 14 $2K
J2704 Injection, propofol, 10 mg <1% 3,871 $2K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 199 $2K
99384 <1% 12 $2K
80177 <1% 147 $2K
88311 <1% 300 $2K
90723 <1% 175 $2K
82670 <1% 176 $2K
29125 <1% 514 $2K
87205 <1% 1,299 $2K
85379 <1% 923 $2K
90680 <1% 166 $2K
86256 <1% 149 $1K
85613 <1% 155 $1K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 66 $1K
82024 <1% 154 $1K
92551 <1% 269 $1K
84432 <1% 213 $1K
93017 <1% 26 $1K
76604 <1% 114 $1K
86334 <1% 136 $1K
82390 <1% 205 $1K
0031A <1% 34 $1K
85045 <1% 433 $1K
87040 <1% 2,286 $1K
95812 <1% 31 $1K
92650 <1% 41 $1K
73000 <1% 136 $1K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 247 $1K
82040 <1% 325 $1K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,602 $1K
82140 <1% 244 $1K
84681 <1% 144 $1K
28470 <1% 45 $1K
83605 <1% 4,384 $1K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 43 $1K
86580 <1% 293 $1K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 195 $1K
92134 <1% 32 $983.73
92228 <1% 46 $960.90
88342 <1% 25 $944.20
82945 <1% 387 $921.89
90746 <1% 12 $906.27
73620 <1% 93 $888.62
93272 <1% 40 $878.95
26720 <1% 34 $850.00
97802 <1% 12 $847.83
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 429 $843.77
90633 <1% 89 $841.05
0054A <1% 21 $840.00
99241 <1% 29 $836.75
84436 <1% 193 $836.17
92015 Determination of refractive state <1% 214 $803.76
82952 <1% 265 $760.23
29515 <1% 200 $757.16
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient <1% 12 $732.59
86146 <1% 25 $724.56
12011 <1% 430 $720.75
83498 <1% 49 $714.53
99242 <1% 13 $702.14
86870 <1% 28 $698.55
29075 <1% 28 $680.25
J1815 Injection, insulin, per 5 units <1% 564 $658.56
86923 <1% 134 $636.64
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 4,081 $590.16
90649 <1% 59 $557.55
82747 <1% 129 $548.72
72202 <1% 54 $529.94
Z1038 <1% 12 $526.84
84166 <1% 132 $516.94
90710 <1% 54 $510.30
99188 <1% 52 $504.90
92558 <1% 16 $504.00
86008 <1% 14 $503.72
90700 <1% 51 $481.95
84270 <1% 44 $458.45
74220 <1% 14 $452.60
J3475 Injection, magnesium sulfate, per 500 mg <1% 567 $448.07
93880 <1% 14 $437.27
88104 <1% 28 $433.86
87338 <1% 42 $422.74
86709 <1% 49 $402.95
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 347 $346.62
72046 <1% 19 $342.90
73070 <1% 50 $328.34
73600 <1% 23 $305.97
81002 <1% 1,058 $304.23
86671 <1% 12 $300.61
80143 <1% 1,273 $295.38
J1630 Injection, haloperidol, up to 5 mg <1% 616 $293.88
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 42 $284.66
J2060 Injection, lorazepam, 2 mg <1% 1,631 $271.33
10060 <1% 485 $266.81
80164 <1% 62 $258.74
83993 <1% 14 $251.28
86335 <1% 27 $244.57
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 1,613 $244.34
90734 <1% 25 $236.25
84630 <1% 25 $222.39
84244 <1% 18 $219.35
82103 <1% 27 $219.11
86787 <1% 44 $218.38
80179 <1% 819 $215.63
77063 Screening digital breast tomosynthesis, bilateral <1% 30 $197.53
84145 <1% 243 $195.66
J7050 Infusion, normal saline solution, 250 cc <1% 39 $194.34
80189 <1% 12 $192.49
A4217 Sterile water/saline, 500 ml <1% 628 $189.70
83930 <1% 43 $179.54
92552 <1% 12 $158.64
86753 <1% 12 $158.53
82239 <1% 33 $157.33
97750 <1% 877 $135.42
76937 <1% 36 $134.61
82010 <1% 734 $127.80
84466 <1% 26 $121.71
J1644 Injection, heparin sodium, per 1000 units <1% 254 $121.40
76775 <1% 12 $108.65
J1940 Injection, furosemide, up to 20 mg <1% 65 $108.22
84300 <1% 43 $107.57
74022 <1% 117 $105.88
87045 <1% 12 $102.17
81000 <1% 48 $98.98
73020 <1% 15 $92.55
84133 <1% 41 $87.77
J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg <1% 113 $86.02
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 319 $85.15
83935 <1% 15 $81.87
82803 <1% 202 $79.41
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 743 $78.54
80329 <1% 243 $75.96
82085 <1% 12 $71.64
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 94 $69.02
99607 <1% 41 $66.00
90673 <1% 140 $62.78
92133 <1% 17 $62.08
83021 <1% 12 $58.37
G9008 Coordinated care fee, physician coordinated care oversight services <1% 2,956 $44.67
36000 <1% 36 $34.16
J3370 Injection, vancomycin hcl, 500 mg <1% 233 $26.10
0250 <1% 355 $21.69
92020 <1% 14 $17.29
J0780 Injection, prochlorperazine, up to 10 mg <1% 211 $15.78
J1650 Injection, enoxaparin sodium, 10 mg <1% 426 $11.40
87807 <1% 51 $7.20
0270 <1% 25 $0.30
3079F 0% 217 $0.00
3074F 0% 720 $0.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 0% 146 $0.00
S0020 Injection, bupivicaine hydrochloride, 30 ml 0% 24 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 0% 50 $0.00
3075F 0% 29 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 0% 55 $0.00
99156 0% 28 $0.00
0258 0% 22 $0.00
G0442 Annual alcohol misuse screening, 5 to 15 minutes 0% 12 $0.00
G0008 Administration of influenza virus vaccine 0% 12 $0.00
3078F 0% 634 $0.00
3077F 0% 104 $0.00
51702 0% 15 $0.00
99173 0% 39 $0.00
J1953 Injection, levetiracetam, 10 mg 0% 41 $0.00
99157 0% 26 $0.00
0272 0% 25 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCANTU, ANDREW (CHIEF FINANCIAL OFFICER)
Same official

Other billing entities under CANTU, ANDREW

Full network →
ProviderLocationPaid
Kern County Hospital AuthorityBakersfield, CA$262K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.